New gold-based drug proves to be more potent than standard chemotherapy

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.

Robotics Companies & Solutions for the Pharmaceutical Industry

Robotics companies are playing an increasingly pivotal role within the pharmaceutical industry. Robotic automation companies are vastly increasing the capability of modern pharmaceutical businesses. For

October 1, 2024

Compressed workweeks help employees detach but do not reduce burnout risk

Condensing workweeks into fewer days to enjoy more days off, what are the implications for employee well-being? New longitudinal research from Ghent University at IKEA

January 27, 2025

Risk Adjusted Net Present Value: What is the current valuation of Unicycive Therapeutics’s RenaZorb

The revenue for RenaZorb is expected to reach an annual total of $308 mn by 2026 in the US based off GlobalData’s Expiry Model. The

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.